Specialty Pharmacy Trends in Personal Injury: High-Cost Medications and Liens

James Wong — Founder & CEO, LienScripts | March 4, 2026 | 7 min read

Specialty pharmacy medications are increasingly prescribed for severe personal injury cases. LienScripts pharmacy lien services ensure access to specialty medications without the insurance barriers, prior authorization delays, and distribution restrictions that typically limit specialty drug access.

Specialty pharmacy medications are high-cost, complex drugs that typically require special handling, administration, or monitoring. In personal injury cases, specialty medications may be prescribed for severe pain syndromes, complex inflammatory conditions, neurological injuries, and conditions exacerbated by trauma. The specialty pharmacy market continues to grow rapidly in 2026, and these medications increasingly appear in PI cases involving catastrophic injuries. Pharmacy lien services through LienScripts provide access to specialty medications through the same lien mechanism used for standard prescriptions, eliminating the insurance barriers that make specialty drugs particularly difficult for injured plaintiffs to obtain.

• Specialty medications account for over 50% of total drug spending in the U.S. despite representing less than 3% of all prescriptions
• Specialty drugs commonly relevant to PI cases include biologics for inflammatory conditions, injectable pain medications, and neurological agents
• Insurance barriers for specialty medications are significantly higher than for standard drugs, including mandatory prior authorization, step therapy, and specialty pharmacy restrictions
• LienScripts pharmacy lien services provide specialty medication access without insurance barriers or specialty pharmacy network restrictions
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages

What Makes a Medication "Specialty"

Specialty medications are generally defined by one or more of the following characteristics: they are biologic or biosimilar products, they require special storage or handling, they are administered by injection or infusion, they require ongoing clinical monitoring, or they treat complex or rare conditions. The common thread is complexity that goes beyond standard prescription dispensing.

For personal injury cases, specialty medications enter the picture when injuries are severe enough to require complex pharmaceutical interventions:

Injectable pain management. Certain injectable medications for severe chronic pain syndromes that develop after traumatic injury are classified as specialty drugs.

Biologic therapy. Biosimilars and reference biologics for inflammatory conditions exacerbated by injury are dispensed through specialty pharmacy channels.

Neurological medications. Medications for traumatic brain injury complications, seizure disorders triggered by head trauma, and complex neuropathic conditions may fall into the specialty category.

According to James Wong, PharmD, founder of LienScripts, "Specialty medications are where insurance creates the highest barriers. Multiple rounds of prior authorization, mandatory specialty pharmacy use, quantity limitations, and ongoing recertification requirements. The pharmacy lien cuts through all of that complexity."

Insurance Barriers for Specialty Medications

The insurance and PBM system imposes significantly more barriers on specialty medications than on standard prescriptions:

Mandatory Prior Authorization

Virtually all specialty medications require prior authorization, often with clinical documentation requirements that are more extensive than standard PA. The prescriber must submit detailed clinical notes, diagnostic test results, and treatment history before the insurer will consider approval.

Specialty Pharmacy Network Restrictions

Many insurers require specialty medications to be filled at designated specialty pharmacies, often owned by or affiliated with the PBM. This restriction limits patient choice and can create delivery delays, particularly for patients in areas without a nearby specialty pharmacy location.

Quantity and Refill Limitations

Specialty medications are often dispensed in limited quantities with strict refill windows. Patients may receive only a 30-day supply at a time with no ability to obtain refills early, even when traveling or facing other logistical challenges.

Ongoing Recertification

Insurance coverage for specialty medications typically requires periodic recertification, where the prescriber must resubmit clinical documentation to confirm continued medical necessity. Missed recertification deadlines result in coverage denial.

How LienScripts Handles Specialty Medications

The LienScripts pharmacy lien model provides specialty medication access through the same mechanism used for all injury-related prescriptions:

• The prescriber writes the specialty medication order based on clinical need
• LienScripts coordinates dispensing through network pharmacies with specialty capabilities
• No prior authorization, specialty pharmacy network restriction, or recertification applies
• The patient receives the medication at zero upfront cost under the lien
• The MERIT report documents every specialty dispensing for the demand package

For attorneys managing cases with complex medication documentation needs, the MERIT report provides a unified view of both standard and specialty medications dispensed under the lien.

Impact on Case Value

Specialty medications can significantly affect case value because of their higher per-unit costs. Attorneys should be aware of several dynamics:

Documentation Is Critical

Because specialty medications represent significant lien amounts, thorough documentation of medical necessity is essential. The prescriber's clinical rationale for the specialty medication must clearly connect the drug to the injury.

Defense Scrutiny Is Higher

Defense counsel is more likely to challenge specialty medication charges than standard prescription costs. Having pharmacist-level documentation from the MERIT report, combined with prescriber records establishing medical necessity, provides a strong foundation for defending specialty medication charges.

Treatment Timeline Matters

Specialty medications are typically prescribed after standard treatments have been tried. The MERIT report documents this progression, showing that the treatment escalation was clinically appropriate and not a jump to expensive therapy without justification.

For guidance on pharmacy lien pricing in litigation, the defense of specialty medication charges follows the same principles as standard lien pricing defense.

The Growth Trajectory

The specialty pharmacy market is projected to continue growing as more biologic and specialty products enter the market. For personal injury practice, this means attorneys will encounter specialty medications with increasing frequency in severe injury cases. Establishing pharmacy lien relationships through LienScripts ensures that clients have access to specialty medications from the start of treatment, without the insurance barriers that can delay or prevent access to these complex therapies.